Safety and Efficacy Study of OMS906 in Patients With C3G and ICGN

Clinical trial NCT06209736 · RECRUITING

Trial details

NCT number: NCT06209736
Sponsor: Omeros Corporation
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

C3 Glomerulopathy Idiopathic Immune Complex-Mediated Glomerulonephritis

Start date: 2024-03-01
Primary completion: 2026-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.